# Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays

> **NCT01194622** · PHASE1 · COMPLETED · sponsor: **MEDA Pharma GmbH & Co. KG** · enrollment: 30 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Azelastine, Fluticasone
- **DRUG:** Fluticasone mono
- **DRUG:** Fluticasone

## Key facts

- **NCT ID:** NCT01194622
- **Lead sponsor:** MEDA Pharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01194622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01194622, "Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01194622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*